{
  "meta": {
    "id": "test2",
    "title": "OBG E&D (Mission NEET PG_INICET 2.0) - 16-07-2024 - 2024-07-16",
    "category": "INICET PYQ"
  },
  "questions": [
    {
      "text": "A 23 y P2L2 comes to the OPD. She says that she missed her period by 10 days and is now complaining of spotting. There is also mild abdominal pain. On examination the uterus is 6 weeks size and the os is closed. Which is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Complete abortion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Incomplete abortion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inevitable abortion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Threatened abortion",
          "correct": true
        }
      ],
      "correct_answer": "D. Threatened abortion",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Threatened abortion</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A threatened abortion is characterized by vaginal bleeding and mild abdominal pain in early pregnancy, with a closed cervical os and an intact pregnancy. These symptoms indicate a potential risk of miscarriage, but the pregnancy has not yet ended.</li><li>\u27a4 threatened abortion</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b7d09dc6",
      "audio": ""
    },
    {
      "text": "A 26y old gives a history of two 1st trimester abortions following delivery of a preterm baby at 30 weeks due to severe preeclampsia. She is anxious and wants to be evaluated preconceptionally. Which of the following investigation will you advise?",
      "options": [
        {
          "label": "A",
          "text": "Lupus anticoagulant",
          "correct": true
        },
        {
          "label": "B",
          "text": "HBA1C",
          "correct": false
        },
        {
          "label": "C",
          "text": "TSH",
          "correct": false
        },
        {
          "label": "D",
          "text": "TORCH",
          "correct": false
        }
      ],
      "correct_answer": "A. Lupus anticoagulant",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Lupus anticoagulant</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Antiphospholipid Antibody Syndrome (APLA) should be suspected in women with recurrent first-trimester abortions and preeclampsia leading to preterm delivery before 34 weeks. Diagnostic evaluation includes testing for lupus anticoagulant, anti-cardiolipin antibodies, and beta-2 glycoprotein I antibodies.</li><li>\u27a4 Antiphospholipid Antibody Syndrome (APLA)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bbf2b254",
      "audio": ""
    },
    {
      "text": "All the following are risk factors for developing cervical insufficiency except?",
      "options": [
        {
          "label": "A",
          "text": "Conization",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dilatation and curettage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Endometrial biopsy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Trachelectomy",
          "correct": false
        }
      ],
      "correct_answer": "C. Endometrial biopsy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Endometrial biopsy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cervical insufficiency can result from procedures that damage or remove portions of the cervix, such as conization, dilatation and curettage, or trachelectomy. Endometrial biopsy , however, does not affect the cervical tissue and is not a risk factor for cervical insufficiency.</li><li>\u27a4 Endometrial biopsy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2ca5fbdb",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman presents for a routine checkup. She has a sedentary lifestyle, and her BMI is 26. She used to smoke 1 pack/day but has recently stopped. She was advised calcium and vitamin D supplementation at her last checkup but has not been taking these. She has no significant medical history. A DEXA scan is done, which shows her T score as -2.5. What is the most appropriate treatment option for her?",
      "options": [
        {
          "label": "A",
          "text": "Bisphosphonates",
          "correct": true
        },
        {
          "label": "B",
          "text": "Calcium + Vitamin D supplementation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Estrogen + Progesterone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Teriparatide",
          "correct": false
        }
      ],
      "correct_answer": "A. Bisphosphonates",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Bisphosphonates</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Bisphosphonates are the first-line treatment for postmenopausal women diagnosed with osteoporosis (T-score \u2264 -2.5). These medications reduce bone resorption and increase bone density, significantly lowering the risk of fractures. Calcium and vitamin D supplementation is essential as an adjunct therapy but not sufficient as standalone treatment for osteoporosis.</li><li>\u27a4 Bisphosphonates</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5daa79f",
      "audio": ""
    },
    {
      "text": "Which is incorrect regarding Hormone Replacement Therapy in menopause?",
      "options": [
        {
          "label": "A",
          "text": "It is effective for vasomotor symptoms during perimenopausal period",
          "correct": false
        },
        {
          "label": "B",
          "text": "It should be given for young women with premature menopause",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is useful for primary prevention of heart disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cyclical HRT is preferred over continuous HRT in perimenopausal women",
          "correct": false
        }
      ],
      "correct_answer": "C. It is useful for primary prevention of heart disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It is useful for primary prevention of heart disease</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HRT should not be used for the primary prevention of cardiovascular disease due to its association with an increased risk of heart attacks and strokes. It is primarily used to relieve menopausal symptoms and in specific cases such as premature menopause.</li><li>\u27a4 HRT should not be used for the primary prevention of cardiovascular disease</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b93ee0a4",
      "audio": ""
    },
    {
      "text": "A 24-year-old primigravida at 36 weeks complains of decreased fetal movements since 1 day. The following test was ordered. What is this test?",
      "options": [
        {
          "label": "A",
          "text": "Biophysical profile",
          "correct": false
        },
        {
          "label": "B",
          "text": "Doppler",
          "correct": false
        },
        {
          "label": "C",
          "text": "Non-Stress Test",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "C. Non-Stress Test",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-143851.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Non-Stress Test</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A Non-Stress Test (NST) is a non-invasive method to monitor fetal heart rate patterns in response to fetal movements. It is commonly used in the third trimester when concerns about fetal well-being arise, such as decreased fetal movements.</li><li>\u27a4 Non-Stress Test (NST)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f13b7c79",
      "audio": ""
    },
    {
      "text": "A 22-year-old G2P1 with a history of a previous term stillbirth is now 37 weeks pregnant. She complains of decreased fetal movements for 2 days. A Biophysical Profile is ordered. All are components of the Biophysical Profile except?",
      "options": [
        {
          "label": "A",
          "text": "Amniotic Fluid measurement",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fetal tone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fetal breathing",
          "correct": false
        },
        {
          "label": "D",
          "text": "Umbilical Artery Doppler",
          "correct": true
        }
      ],
      "correct_answer": "D. Umbilical Artery Doppler",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Umbilical Artery Doppler</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Biophysical Profile (BPP) consists of five components: fetal breathing movements, fetal movements, fetal tone, amniotic fluid volume, and the non-stress test (NST). Umbilical Artery Doppler is not a part of the BPP but is a separate test used to assess placental blood flow.</li><li>\u27a4 Biophysical Profile (BPP)</li><li>\u27a4 Umbilical Artery Doppler</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "863d73a3",
      "audio": ""
    },
    {
      "text": "A 26-year-old lady with mild pre-eclampsia presents at 32 weeks. On abdominal examination, the uterus corresponds to 28 weeks, and the fetal heart rate is 132 bpm. An ultrasound is advised. The following image shows an umbilical artery Doppler. What is your interpretation?",
      "options": [
        {
          "label": "A",
          "text": "Absent diastolic flow",
          "correct": true
        },
        {
          "label": "B",
          "text": "Normal diastolic flow",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reduced diastolic flow",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reversal of diastolic flow",
          "correct": false
        }
      ],
      "correct_answer": "A. Absent diastolic flow",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-144131.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Absent diastolic flow</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of fetal growth restriction and placental insufficiency, absent diastolic flow in the umbilical artery Doppler is a concerning finding. It often indicates that delivery should be considered, especially if the gestational age is beyond 34 weeks, or if the fetus shows signs of distress.</li><li>\u27a4 absent diastolic flow</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "098ccaf7",
      "audio": ""
    },
    {
      "text": "A 23-year-old woman has been taking Oral Contraceptive Pills (OCPs) regularly for the past two years. She presents to the family planning OPD on Day 8 of her cycle with the complaint that she has missed taking two pills on Day 7 and Day 8. What will you advise her?",
      "options": [
        {
          "label": "A",
          "text": "Take the last missed pill as soon as possible and continue the remaining packet",
          "correct": true
        },
        {
          "label": "B",
          "text": "Take the missed pill as soon as possible and offer her emergency contraception also",
          "correct": false
        },
        {
          "label": "C",
          "text": "Take the missed pill as soon as possible and use additional contraception for 7 days",
          "correct": false
        },
        {
          "label": "D",
          "text": "Take the missed pill as soon as possible, use emergency contraception and discard the remaining packet",
          "correct": false
        }
      ],
      "correct_answer": "A. Take the last missed pill as soon as possible and continue the remaining packet",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Take the last missed pill as soon as possible and continue the remaining packet</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For women who miss one or two pills , they should take the missed pills immediately and continue with the regular schedule without needing additional contraception. Only if three or more pills are missed is there a need for extra precautions, such as additional contraception or emergency contraception, depending on the timing of the missed pills.</li><li>\u27a4 one or two pills</li><li>\u27a4 take the missed pills immediately</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8747c6c3",
      "audio": ""
    },
    {
      "text": "All are true regarding postpartum contraception except:",
      "options": [
        {
          "label": "A",
          "text": "With full or near full breast-feeding, 70% of women remain amenorrheic through 6 months",
          "correct": false
        },
        {
          "label": "B",
          "text": "With partial feeding or no breast feeding, a contraceptive method should begin during the 3rd postpartum week",
          "correct": false
        },
        {
          "label": "C",
          "text": "The progestin only minipill does not affect lactation",
          "correct": false
        },
        {
          "label": "D",
          "text": "The vaginal ring can be used effectively in breast feeding mothers as absorption of estrogen is minimal and does not affect lactation.",
          "correct": true
        }
      ],
      "correct_answer": "D. The vaginal ring can be used effectively in breast feeding mothers as absorption of estrogen is minimal and does not affect lactation.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Estrogen-containing contraceptives , including the vaginal ring, are generally not recommended during breastfeeding because they can reduce milk production. Progestin-only methods are the preferred choice for postpartum contraception in breastfeeding women.</li><li>\u27a4 Estrogen-containing contraceptives</li><li>\u27a4 not recommended during breastfeeding</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e339764",
      "audio": ""
    },
    {
      "text": "An intrauterine pregnancy of approximately 10 weeks gestation is confirmed in a 30-year-old gravida 5, para 4 woman with an intrauterine device (IUD) in place. The patient expresses a strong desire for the pregnancy to be continued. On examination, the uterus is 10 weeks in size, and the string of the IUD is noted to be protruding from the cervical os. The most appropriate course of action is:",
      "options": [
        {
          "label": "A",
          "text": "Leave the IUD in place without any other treatment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leave the IUD in place and start prophylactic antibiotics",
          "correct": false
        },
        {
          "label": "C",
          "text": "Remove the IUD immediately",
          "correct": true
        },
        {
          "label": "D",
          "text": "USG to rule out ectopic pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "C. Remove the IUD immediately",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Remove the IUD immediately</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of intrauterine pregnancy with an IUD in place, the IUD should be removed as soon as possible if the strings are visible and accessible. This minimizes the risk of miscarriage, infection, and preterm labor. If there is any concern regarding ectopic pregnancy, an ultrasound should be performed to confirm the intrauterine location of the pregnancy.</li><li>\u27a4 IUD should be removed as soon as possible</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "34738fd1",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman presents with infertility and is diagnosed with anovulatory cycles. Which of the following medications can be used for ovulation induction in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Clomiphene citrate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Letrozole",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both clomiphene citrate and letrozole",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gonadotropin-releasing hormone (GnRH) agonists",
          "correct": false
        }
      ],
      "correct_answer": "C. Both clomiphene citrate and letrozole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Both clomiphene citrate and letrozole</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Both clomiphene citrate and letrozole are effective medications for ovulation induction in women with anovulatory infertility. Clomiphene acts by blocking estrogen receptors, while letrozole reduces estrogen production, both leading to increased FSH release and stimulation of ovulation.</li><li>\u27a4 clomiphene citrate</li><li>\u27a4 letrozole</li><li>\u27a4 ovulation induction</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ceaa7aa1",
      "audio": ""
    },
    {
      "text": "Match the following drugs used in gynecology with their corresponding indications:",
      "options": [
        {
          "label": "A",
          "text": "A-2, B-1, C-4, D-3",
          "correct": false
        },
        {
          "label": "B",
          "text": "A-1, B-2, C-4, D-3",
          "correct": true
        },
        {
          "label": "C",
          "text": "A-3, B-1, C-2, D-4",
          "correct": false
        },
        {
          "label": "D",
          "text": "A-4, B-2, C-1, D-3",
          "correct": false
        }
      ],
      "correct_answer": "B. A-1, B-2, C-4, D-3",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-173725.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-173527.png"
      ],
      "explanation": "<p><strong>Ans. B) A-1, B-2, C-4, D-3</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b5caea7",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman presents with heavy menstrual bleeding and dysmenorrhea. Pelvic ultrasound reveals an intramural fibroid measuring 3 cm. The woman desires medical management rather than surgical intervention. Which of the following would be the most appropriate first-line drug in this woman?",
      "options": [
        {
          "label": "A",
          "text": "Antifibrinolytic with NSAID",
          "correct": true
        },
        {
          "label": "B",
          "text": "Combined estrogen progesterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "GnRH antagonist",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ulipristal acetate",
          "correct": false
        }
      ],
      "correct_answer": "A. Antifibrinolytic with NSAID",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Antifibrinolytic with NSAID</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For the first-line medical management of heavy menstrual bleeding and dysmenorrhea due to fibroids, antifibrinolytics combined with NSAIDs are effective and well-tolerated. These treatments reduce menstrual blood loss and alleviate pain, offering a non-surgical option for symptom control.</li><li>\u27a4 antifibrinolytics</li><li>\u27a4 NSAIDs</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7ec1eec",
      "audio": ""
    },
    {
      "text": "A 33-year-old woman comes to the OPD with amenorrhea of 6 weeks. Her urine pregnancy test is positive. A transvaginal ultrasound is done, which shows a normal uterus and adnexa. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Complete abortion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ectopic pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pregnancy of undetermined location",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pseudocyesis",
          "correct": false
        }
      ],
      "correct_answer": "C. Pregnancy of undetermined location",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pregnancy of undetermined location</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A pregnancy of undetermined location (PUL) is diagnosed when there is a positive pregnancy test but no clear signs of an intrauterine or ectopic pregnancy on ultrasound. Further monitoring with serial beta-hCG levels and follow-up ultrasounds are necessary to determine the pregnancy\u2019s location and viability.</li><li>\u27a4 pregnancy of undetermined location (PUL)</li><li>\u27a4 beta-hCG levels</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a256d5a9",
      "audio": ""
    },
    {
      "text": "A 34-year-old woman presents to the gynecology OPD with an ultrasound report confirming an unruptured tubal ectopic pregnancy. She has no symptoms and is hemodynamically stable. Her \u03b2-hCG level is 600 IU/L. The scan shows a gestational sac measuring 20 mm in the right adnexa with no yolk sac or embryo seen. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Expectant management",
          "correct": true
        },
        {
          "label": "B",
          "text": "Single dose inj Methotrexate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Laparoscopic salpingostomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Laparoscopic salpingotomy",
          "correct": false
        }
      ],
      "correct_answer": "A. Expectant management",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Expectant management</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with an unruptured, asymptomatic ectopic pregnancy and low \u03b2-hCG levels (<1,000 IU/L) , expectant management is an appropriate option. Regular follow-up with serial \u03b2-hCG measurements is necessary to confirm that the pregnancy is resolving spontaneously.</li><li>\u27a4 \u03b2-hCG levels (<1,000 IU/L)</li><li>\u27a4 expectant management</li><li>\u27a4 \u03b2-hCG</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2687e62",
      "audio": ""
    },
    {
      "text": "Of mullerian defects, which has the lowest associated risk of recurrent miscarriage and is shown here in this three-dimensional sonographic image?",
      "options": [
        {
          "label": "A",
          "text": "Septate uterus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Arcuate uterus",
          "correct": true
        },
        {
          "label": "C",
          "text": "Uterus didelphys",
          "correct": false
        },
        {
          "label": "D",
          "text": "Unicornuate uterus",
          "correct": false
        }
      ],
      "correct_answer": "B. Arcuate uterus",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-145920.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Arcuate uterus</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 An arcuate uterus is a mild form of M\u00fcllerian anomaly associated with the lowest risk of recurrent miscarriage compared to other uterine anomalies. It generally allows for successful pregnancies with minimal complications.</li><li>\u27a4 arcuate uterus</li><li>\u27a4 lowest risk of recurrent miscarriage</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7bf4f2f0",
      "audio": ""
    },
    {
      "text": "Characteristics of the soft, fleshy intrauterine growth, shown here exhibiting a single feeder vessel, include which of the following?",
      "options": [
        {
          "label": "A",
          "text": "The main diagnostic tool is a Pap smear",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is a rare cause of abnormal uterine bleeding",
          "correct": false
        },
        {
          "label": "C",
          "text": "It commonly causes infertility",
          "correct": false
        },
        {
          "label": "D",
          "text": "Use of combined oral contraceptive pills appears to be protective",
          "correct": true
        }
      ],
      "correct_answer": "D. Use of combined oral contraceptive pills appears to be protective",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-150126.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Use of combined oral contraceptive pills appears to be protective</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Endometrial polyps are common causes of abnormal uterine bleeding and are associated with infertility in some cases. They can be diagnosed via ultrasound with Doppler imaging , and the use of combined oral contraceptives appears to reduce the risk of their development.</li><li>\u27a4 Endometrial polyps</li><li>\u27a4 ultrasound with Doppler imaging</li><li>\u27a4 combined oral contraceptives</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61903b72",
      "audio": ""
    },
    {
      "text": "All can be used as distension media during diagnostic hysteroscopy except:",
      "options": [
        {
          "label": "A",
          "text": "Air",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glycine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Normal Saline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Carbon dioxide",
          "correct": false
        }
      ],
      "correct_answer": "A. Air",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Air</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Air should not be used as a distension medium in hysteroscopy due to the risk of air embolism . Safe alternatives include glycine , normal saline , and carbon dioxide , which provide effective uterine distension with minimal risks.</li><li>\u27a4 Air</li><li>\u27a4 air embolism</li><li>\u27a4 glycine</li><li>\u27a4 normal saline</li><li>\u27a4 carbon dioxide</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ffd7707f",
      "audio": ""
    },
    {
      "text": "A 34-year-old woman with a history of 2 previous abortions presents with secondary infertility. On evaluation, this finding was seen on hysteroscopy. What is the next management option?",
      "options": [
        {
          "label": "A",
          "text": "Hysteroscopic septal resection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hysteroscopic Adhesiolysis",
          "correct": true
        },
        {
          "label": "C",
          "text": "In-vitro fertilization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tubal recanalization",
          "correct": false
        }
      ],
      "correct_answer": "B. Hysteroscopic Adhesiolysis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/whatsapp-image-2024-07-15-at-54921-pm.jpeg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Hysteroscopic Adhesiolysis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of intrauterine adhesions (Asherman\u2019s syndrome) contributing to secondary infertility, hysteroscopic adhesiolysis is the recommended treatment to restore uterine anatomy and improve fertility outcomes.</li><li>\u27a4 intrauterine adhesions (Asherman\u2019s syndrome)</li><li>\u27a4 hysteroscopic adhesiolysis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b23c8a72",
      "audio": ""
    },
    {
      "text": "A 28-year-old G1P1 woman complains of significant dysmenorrhea & dyspareunia. She has regular periods & has no past history of any abdominal surgery or any vaginal infection. Which of the following tests would most likely identify the etiology of the infertility in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Laparoscopy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Basal body temperature chart",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hysterosalpingogram",
          "correct": false
        },
        {
          "label": "D",
          "text": "Progesterone assay",
          "correct": false
        }
      ],
      "correct_answer": "A. Laparoscopy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Laparoscopy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Laparoscopy is the most appropriate test to identify the etiology of infertility in a patient with symptoms suggestive of endometriosis . It allows for direct visualization and diagnosis of endometrial implants, adhesions, and other pelvic abnormalities that can cause infertility and pelvic pain.</li><li>\u27a4 Laparoscopy</li><li>\u27a4 endometriosis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56cab239",
      "audio": ""
    },
    {
      "text": "A 32-year-old lady presents to the OPD. She had a Copper T inserted 5 years earlier and now wants to conceive. She has come for removal of the Copper T. Which instruments are required for this procedure? Cuscos speculum Vulsellum Uterine sound Artery forceps Anterior vaginal wall retractor Allis forceps",
      "options": [
        {
          "label": "A",
          "text": "a, d",
          "correct": true
        },
        {
          "label": "B",
          "text": "a, b, f",
          "correct": false
        },
        {
          "label": "C",
          "text": "a, b, c, d",
          "correct": false
        },
        {
          "label": "D",
          "text": "a, b, c, d, e",
          "correct": false
        }
      ],
      "correct_answer": "A. a, d",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) a, d</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For the removal of a Copper T , the essential instruments are Cusco's speculum for visualization and artery forceps to grasp and remove the IUD. Additional instruments are only needed if complications arise.</li><li>\u27a4 removal of a Copper T</li><li>\u27a4 Cusco's speculum</li><li>\u27a4 artery forceps</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a31cc0f",
      "audio": ""
    },
    {
      "text": "In which surgery would the instrument shown below be used?",
      "options": [
        {
          "label": "A",
          "text": "Abdominal hysterectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vaginal hysterectomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ovarian cystectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tubal ligation",
          "correct": true
        }
      ],
      "correct_answer": "D. Tubal ligation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-152704.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Tubal ligation</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The tubal forceps shown in the image is primarily used in tubal ligation procedures, where the fallopian tubes are manipulated for occlusion as a form of permanent contraception.</li><li>\u27a4 tubal forceps</li><li>\u27a4 tubal ligation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "64ceddfd",
      "audio": ""
    },
    {
      "text": "Identify the procedure being done in the image:",
      "options": [
        {
          "label": "A",
          "text": "Cervical biopsy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cervical conization",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cervical cerclage",
          "correct": false
        },
        {
          "label": "D",
          "text": "Large loop excision of the transformation zone (LEEP)",
          "correct": true
        }
      ],
      "correct_answer": "D. Large loop excision of the transformation zone (LEEP)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-152843.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)\u00a0Large loop excision of the transformation zone (LEEP)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Large Loop Excision of the Transformation Zone (LEEP) is a procedure used to remove abnormal cervical tissue, typically in cases of cervical dysplasia or CIN. It serves both as a treatment and diagnostic tool.</li><li>\u27a4 Large Loop Excision of the Transformation Zone (LEEP)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "77d4ba2f",
      "audio": ""
    },
    {
      "text": "All are true regarding post evacuation surveillance of a Hydatiform mole except?",
      "options": [
        {
          "label": "A",
          "text": "Incidence of gestational trophoblastic neoplasia is higher following a partial mole.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Serial measurement of \u03b2 hCG is done to detect persistent trophoblastic proliferation.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Initial baseline serum \u03b2hCG measurement is taken 48h post evacuation",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u03b2-hCG is done weekly till negative then monthly till 6 months",
          "correct": false
        }
      ],
      "correct_answer": "A. Incidence of gestational trophoblastic neoplasia is higher following a partial mole.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the post-evacuation surveillance of a hydatidiform mole , complete moles have a higher risk of progressing to gestational trophoblastic neoplasia (GTN) compared to partial moles. Serial \u03b2-hCG monitoring is essential to detect persistent disease, and the initial baseline measurement is taken 48 hours post-evacuation, with follow-up weekly and then monthly once levels normalize.</li><li>\u27a4 hydatidiform mole</li><li>\u27a4 gestational trophoblastic neoplasia (GTN)</li><li>\u27a4 Serial \u03b2-hCG</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "58ab6a38",
      "audio": ""
    },
    {
      "text": "Karyotype of a complete mole is:",
      "options": [
        {
          "label": "A",
          "text": "69XXY",
          "correct": false
        },
        {
          "label": "B",
          "text": "69XXX",
          "correct": false
        },
        {
          "label": "C",
          "text": "46XX",
          "correct": true
        },
        {
          "label": "D",
          "text": "45XO",
          "correct": false
        }
      ],
      "correct_answer": "C. 46XX",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A complete mole usually has a 46XX karyotype, resulting from the fertilization of an empty egg by a sperm that then duplicates, leading to abnormal trophoblastic growth and no fetal development.</li><li>\u27a4 complete mole</li><li>\u27a4 46XX</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2673d713",
      "audio": ""
    },
    {
      "text": "A 24-year-old primigravida is in labor in the 2nd stage. The resident asks the nurse to keep everything ready for the active management of the 3rd stage of labor. What drug should the nurse have ready?",
      "options": [
        {
          "label": "A",
          "text": "Injection Carboprost",
          "correct": false
        },
        {
          "label": "B",
          "text": "Injection Oxytocin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Injection Tranexamic Acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Injection Methergine",
          "correct": false
        }
      ],
      "correct_answer": "B. Injection Oxytocin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Injection Oxytocin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The active management of the 3rd stage of labor involves the administration of oxytocin to promote uterine contractions and prevent postpartum hemorrhage. It is the first-line drug for this purpose, ensuring safe delivery and reducing the risk of excessive bleeding.</li><li>\u27a4 active management of the 3rd stage of labor</li><li>\u27a4 oxytocin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "17e98d65",
      "audio": ""
    },
    {
      "text": "While assisting a cesarean section for placenta previa, the patient starts bleeding. The gynecologist applies the following suture on the uterus and asks the name of it. What is this suture called?",
      "options": [
        {
          "label": "A",
          "text": "Cho\u2019s suture",
          "correct": false
        },
        {
          "label": "B",
          "text": "B-Lynch suture",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hayman suture",
          "correct": false
        },
        {
          "label": "D",
          "text": "Isthmic cervical apposition",
          "correct": false
        }
      ],
      "correct_answer": "B. B-Lynch suture",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-153359.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) B-Lynch suture</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The B-Lynch suture is a commonly used uterine compression suture to control postpartum hemorrhage, particularly in cases of uterine atony or placenta previa. It works by compressing the uterus and helping to stop bleeding, often used during cesarean sections.</li><li>\u27a4 B-Lynch suture</li><li>\u27a4 uterine compression suture</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d53dd64",
      "audio": ""
    },
    {
      "text": "Choose the incorrect statements regarding management of PPH:",
      "options": [
        {
          "label": "A",
          "text": "Uterine massage is first step in management.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oxytocin is given to all patients.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Suction and evacuation is done",
          "correct": true
        },
        {
          "label": "D",
          "text": "B-lynch suture is put if medical management fails",
          "correct": false
        }
      ],
      "correct_answer": "C. Suction and evacuation is done",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the management of postpartum hemorrhage, the first steps include uterine massage and the administration of oxytocin . If these measures fail, additional uterotonics or surgical interventions such as the B-Lynch suture may be required. Suction and evacuation is not typically part of the routine management of PPH, unless there is suspicion of retained products of conception.</li><li>\u27a4 uterine massage</li><li>\u27a4 oxytocin</li><li>\u27a4 B-Lynch suture</li><li>\u27a4 Suction and evacuation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3543ed82",
      "audio": ""
    },
    {
      "text": "Which of the following is a not a component of AMTSL?",
      "options": [
        {
          "label": "A",
          "text": "Early cord clamping",
          "correct": true
        },
        {
          "label": "B",
          "text": "Uterine massage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Modified Brandt Andrews technique",
          "correct": false
        },
        {
          "label": "D",
          "text": "Uterotonic agents",
          "correct": false
        }
      ],
      "correct_answer": "A. Early cord clamping",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Early cord clamping</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Active Management of the Third Stage of Labor (AMTSL) includes uterotonic administration , uterine massage , and the Modified Brandt Andrews technique . Early cord clamping is not part of AMTSL, as delayed cord clamping is preferred for better neonatal outcomes.</li><li>\u27a4 Active Management of the Third Stage of Labor (AMTSL)</li><li>\u27a4 uterotonic administration</li><li>\u27a4 uterine massage</li><li>\u27a4 Modified Brandt Andrews technique</li><li>\u27a4 Early cord clamping</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2f4b5e9d",
      "audio": ""
    },
    {
      "text": "A couple presents in the 1st trimester and ask about Down syndrome screening. They are very concerned as a relative in the family has Down syndrome. What is the ideal time for doing a Quadruple test?",
      "options": [
        {
          "label": "A",
          "text": "15-18 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "10-12 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "12-14weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "8-10 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. 15-18 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) 15-18 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Quadruple test is ideally performed between 15 and 18 weeks of gestation to screen for Down syndrome and other chromosomal abnormalities. First-trimester screening options are available earlier but involve different methods.</li><li>\u27a4 Quadruple test</li><li>\u27a4 15 and 18 weeks</li><li>\u27a4 Down syndrome</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6ca38f60",
      "audio": ""
    },
    {
      "text": "A pregnant woman (G3P2L0) presented at 9 weeks gestation. She has a history of conization 1 year ago for CIN3 and is currently on follow-up with no recurrence on PAP smear. She also has a history of preterm births at 30 and 32 weeks during her last 2 pregnancies. What is your next step in the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Cervical length measurement on ultrasound",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cervical cerclage",
          "correct": false
        },
        {
          "label": "C",
          "text": "Complete bed rest",
          "correct": false
        },
        {
          "label": "D",
          "text": "Abdominal cerclage",
          "correct": false
        }
      ],
      "correct_answer": "A. Cervical length measurement on ultrasound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Cervical length measurement on ultrasound</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a pregnant woman with a history of cervical conization and preterm births , the next step in management is to measure the cervical length via transvaginal ultrasound . If the cervix is shortened, interventions like cervical cerclage may be considered to prevent preterm birth.</li><li>\u27a4 cervical conization</li><li>\u27a4 preterm births</li><li>\u27a4 cervical length via transvaginal ultrasound</li><li>\u27a4 cervical cerclage</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "646113ce",
      "audio": ""
    },
    {
      "text": "A 29-year-old G2 presents at 33 weeks in preterm labor. Which of the following tocolytics is contraindicated?",
      "options": [
        {
          "label": "A",
          "text": "Atosiban",
          "correct": false
        },
        {
          "label": "B",
          "text": "Indomethacin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Isoxsuprine",
          "correct": false
        },
        {
          "label": "D",
          "text": "MgSO4",
          "correct": false
        }
      ],
      "correct_answer": "B. Indomethacin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Indomethacin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Indomethacin is contraindicated as a tocolytic after 32 weeks of gestation due to the risk of premature closure of the ductus arteriosus and oligohydramnios . Other tocolytics, such as Atosiban and Magnesium sulfate , are safer options in later stages of pregnancy.</li><li>\u27a4 Indomethacin</li><li>\u27a4 32 weeks of gestation</li><li>\u27a4 premature closure of the ductus arteriosus</li><li>\u27a4 oligohydramnios</li><li>\u27a4 Atosiban</li><li>\u27a4 Magnesium sulfate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "80e71080",
      "audio": ""
    },
    {
      "text": "A 21-year-old G2P1 with a history of a prior preterm delivery presents at 32 weeks with abdominal pain. How will you confirm she is in preterm labor?",
      "options": [
        {
          "label": "A",
          "text": "Cervical length on ultrasound",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fetal fibronectin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tocography",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vaginal examination for cervical dilatation",
          "correct": true
        }
      ],
      "correct_answer": "D. Vaginal examination for cervical dilatation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Vaginal examination for cervical dilatation</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The confirmation of preterm labor is based on the presence of cervical dilatation and effacement assessed via vaginal examination , combined with regular uterine contractions. Other methods, like cervical length measurement and fetal fibronectin, assess risk but do not confirm labor.</li><li>\u27a4 confirmation of preterm labor</li><li>\u27a4 cervical dilatation and effacement</li><li>\u27a4 vaginal examination</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "666ca1ee",
      "audio": ""
    },
    {
      "text": "A 15-year-old girl is brought to the OPD by her mother due to concerns that her daughter has not had her menses. She is healthy, has no developmental delay, and is not sexually active. Her maternal aunt has primary infertility, and her maternal grandmother had ovarian cancer. Physical examination shows Tanner stage 5 breast development but scanty axillary and pubic hair. The pelvic exam reveals normal external genitalia but a blind vaginal pouch. Ultrasound shows an absent uterus and ovaries. What is the likely karyotype?",
      "options": [
        {
          "label": "A",
          "text": "47XXY",
          "correct": false
        },
        {
          "label": "B",
          "text": "46 XY",
          "correct": true
        },
        {
          "label": "C",
          "text": "45 XO",
          "correct": false
        },
        {
          "label": "D",
          "text": "46 XX",
          "correct": false
        }
      ],
      "correct_answer": "B. 46 XY",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 46 XY</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Androgen Insensitivity Syndrome (AIS) is characterized by a 46XY karyotype, normal female external genitalia, absent uterus and ovaries, normal breast development, and sparse or absent pubic and axillary hair due to androgen insensitivity.</li><li>\u27a4 Androgen Insensitivity Syndrome (AIS)</li><li>\u27a4 46XY</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "36394d62",
      "audio": ""
    },
    {
      "text": "A 28-year-old nulligravida presents with primary amenorrhea. She is diagnosed with 46XY gonadal dysgenesis. During pelvic laparoscopy, what is the expected finding?",
      "options": [
        {
          "label": "A",
          "text": "Streak gonads and male internal genitalia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Streak gonads and female internal genitalia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Empty pelvis (no gonads or internal genitalia)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bilateral abdominal testes and male internal genitalia",
          "correct": false
        }
      ],
      "correct_answer": "B. Streak gonads and female internal genitalia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Streak gonads and female internal genitalia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In 46XY gonadal dysgenesis (Swyer syndrome) , the expected findings on laparoscopy are streak gonads and female internal genitalia . This condition occurs due to the failure of gonadal development and the absence of sufficient testosterone and M\u00fcllerian-inhibiting factor (AMH), resulting in a female phenotype despite the 46XY karyotype.</li><li>\u27a4 46XY gonadal dysgenesis (Swyer syndrome)</li><li>\u27a4 streak gonads</li><li>\u27a4 female internal genitalia</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c78224fa",
      "audio": ""
    },
    {
      "text": "A 18-year-old girl presents to OPD with primary amenorrhea, normal breast and pubic & axillary hair development. On examination, vagina is absent and there is inguinal hernia. Serum estradiol and FSH level are normal. Ultrasound shows absent uterus and vagina. The likely diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "Complete AIS",
          "correct": false
        },
        {
          "label": "B",
          "text": "Partial AIS",
          "correct": false
        },
        {
          "label": "C",
          "text": "MRKH (Mayer-Rokitansky-K\u00fcster-Hauser syndrome)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Swyer syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. MRKH (Mayer-Rokitansky-K\u00fcster-Hauser syndrome)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) MRKH</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mayer-Rokitansky-K\u00fcster-Hauser (MRKH) syndrome is characterized by the congenital absence of the uterus and upper vagina in individuals with a 46XX karyotype , while maintaining normal ovarian function, which leads to typical female secondary sexual characteristics. It is an important cause of primary amenorrhea in women with normal breast and pubic/axillary hair development.</li><li>\u27a4 Mayer-Rokitansky-K\u00fcster-Hauser (MRKH) syndrome</li><li>\u27a4 46XX karyotype</li><li>\u27a4 primary amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "71105c56",
      "audio": ""
    },
    {
      "text": "A 25-year-old G3P2 presented to the OPD at 29 weeks. Her blood group is B negative and her husband's blood group is B positive. An ICT (indirect Coombs test) revealed high titers of 1 in 32, and an MCA (Middle Cerebral Artery) Doppler shows an increased peak systolic velocity (>1.5 MoM). Which of the following is correct?",
      "options": [
        {
          "label": "A",
          "text": "Amniocentesis for amniotic fluid spectrophotometry",
          "correct": false
        },
        {
          "label": "B",
          "text": "Arrange for cordocentesis and consider Intra uterine transfusion if PCV < 30%",
          "correct": true
        },
        {
          "label": "C",
          "text": "Give Betamethasone for fetal lung maturity and deliver",
          "correct": false
        },
        {
          "label": "D",
          "text": "Repeat MCA PSV after 1 week",
          "correct": false
        }
      ],
      "correct_answer": "B. Arrange for cordocentesis and consider Intra uterine transfusion if PCV < 30%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Arrange for cordocentesis and consider Intra uterine transfusion if PCV < 30%</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of Rh alloimmunization with elevated MCA peak systolic velocity (>1.5 MoM), the next step is cordocentesis to confirm fetal anemia. If fetal hemoglobin levels are low (PCV <30%), intrauterine transfusion is indicated to treat the anemia and improve fetal outcomes.</li><li>\u27a4 Rh alloimmunization</li><li>\u27a4 MCA peak systolic velocity</li><li>\u27a4 cordocentesis</li><li>\u27a4 intrauterine transfusion</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "01cbec7c",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman comes to the OPD for evaluation of absent periods. The patient had a vaginal delivery 8 months ago, and her postpartum course was complicated by secondary PPH requiring blood transfusion and D&E for retained products. She was started on combined OCPs 2 months ago but has not had vaginal bleeding. She had regular monthly cycles before this pregnancy. She is not lactating and is bottle-feeding her baby. There is no headache, galactorrhea, or hot flushes. Her BMI is 31, vitals are normal, and the pelvic exam shows a clear vaginal discharge with a well-rugated vagina. The uterus is small and anteverted. UPT is negative, and FSH and TSH are normal. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Asherman syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sheehan syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "PCOS",
          "correct": false
        },
        {
          "label": "D",
          "text": "Primary ovarian insufficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Asherman syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Asherman syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Asherman syndrome should be suspected in patients with a history of uterine surgery (e.g., D&E for retained products) who present with secondary amenorrhea and normal hormone levels (e.g., FSH, TSH). It is caused by intrauterine adhesions that prevent normal endometrial shedding and menstrual bleeding.</li><li>\u27a4 Asherman syndrome</li><li>\u27a4 amenorrhea</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "030afbeb",
      "audio": ""
    },
    {
      "text": "A newborn was noted to have the following lesion on the scalp. Which drug taken in pregnancy could have caused this?",
      "options": [
        {
          "label": "A",
          "text": "Retinoic acid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propylthiouracil",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phenytoin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methimazole",
          "correct": true
        }
      ],
      "correct_answer": "D. Methimazole",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-155102.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Methimazole use during the first trimester of pregnancy is associated with aplasia cutis congenita , a congenital absence of skin, typically on the scalp. This teratogenic effect makes propylthiouracil the preferred treatment for hyperthyroidism during the first trimester.</li><li>\u27a4 Methimazole</li><li>\u27a4 aplasia cutis congenita</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f23f7bba",
      "audio": ""
    },
    {
      "text": "Which of the following is not seen on examination of a fetus in transverse lie?",
      "options": [
        {
          "label": "A",
          "text": "Uterine height < POG",
          "correct": false
        },
        {
          "label": "B",
          "text": "Grid iron feel",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lower pole empty on pelvic grip",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fetal heart in flank",
          "correct": true
        }
      ],
      "correct_answer": "D. Fetal heart in flank",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Fetal heart in flank</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of transverse lie, the key examination findings include a gridiron feel across the abdomen, an empty lower uterine pole, and often uterine height less than the period of gestation (POG). The fetal heart is typically not auscultated in the flank, but rather in more central locations depending on the exact positioning.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "50396861",
      "audio": ""
    },
    {
      "text": "A 25-year-old woman presents at 37 weeks in early labor. After a few hours, the patient complains of leaking per vaginum. The CTG shows a prolonged deceleration, and on vaginal examination, the cord is felt in the vagina. The cervix is 8 cm dilated. What is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Immediately reposit the cord",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lift the presenting part up",
          "correct": true
        },
        {
          "label": "C",
          "text": "Apply forceps",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cord blood sampling",
          "correct": false
        }
      ],
      "correct_answer": "B. Lift the presenting part up",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of umbilical cord prolapse with fetal distress, the immediate priority is to lift the presenting part to relieve pressure on the cord and maintain blood flow. The patient should then be prepared for emergency cesarean section to expedite delivery and prevent fetal hypoxia.</li><li>\u27a4 umbilical cord prolapse</li><li>\u27a4 lift the presenting part</li><li>\u27a4 emergency cesarean section</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c363681d",
      "audio": ""
    },
    {
      "text": "The incidence of cord prolapse is highest in?",
      "options": [
        {
          "label": "A",
          "text": "Face presentation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Footling breech",
          "correct": true
        },
        {
          "label": "C",
          "text": "Flexed breech",
          "correct": false
        },
        {
          "label": "D",
          "text": "Direct Occipito-posterior",
          "correct": false
        }
      ],
      "correct_answer": "B. Footling breech",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The highest risk of cord prolapse occurs in footling breech presentation , as the feet do not adequately fill the pelvic inlet, leaving space for the cord to descend and prolapse. Prompt recognition and management are critical in such cases to prevent fetal distress.</li><li>\u27a4 cord prolapse</li><li>\u27a4 footling breech presentation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "076caf91",
      "audio": ""
    },
    {
      "text": "Which is not a component of the Modified Bishop score?",
      "options": [
        {
          "label": "A",
          "text": "Position of the cervix",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cervical consistency",
          "correct": false
        },
        {
          "label": "C",
          "text": "Station of the fetal head",
          "correct": false
        },
        {
          "label": "D",
          "text": "Position of the fetal head",
          "correct": true
        }
      ],
      "correct_answer": "D. Position of the fetal head",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Modified Bishop score is used to assess the cervix's readiness for labor and includes parameters like cervical dilatation, effacement, consistency, position , and fetal station . The position of the fetal head is not included in this scoring system.</li><li>\u27a4 Modified Bishop score</li><li>\u27a4 cervical dilatation, effacement, consistency, position</li><li>\u27a4 fetal station</li><li>\u27a4 position of the fetal head</li><li>\u27a4 not</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa0fdd99",
      "audio": ""
    },
    {
      "text": "A patient presents in labor at term. Clinical pelvimetry is performed. She has an oval-shaped pelvis with the antero-posterior diameter at the inlet more than the transverse diameter. On abdominal examination, there is sub-umbilical flattening and the fetal hears is auscultated on the flanks. The most likely kind of pelvis is?",
      "options": [
        {
          "label": "A",
          "text": "A gynecoid pelvis",
          "correct": false
        },
        {
          "label": "B",
          "text": "An android pelvis",
          "correct": false
        },
        {
          "label": "C",
          "text": "An anthropoid pelvis",
          "correct": true
        },
        {
          "label": "D",
          "text": "A platypelloid pelvis",
          "correct": false
        }
      ],
      "correct_answer": "C. An anthropoid pelvis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 An anthropoid pelvis is characterized by an oval-shaped inlet with a longer anteroposterior diameter than the transverse diameter. It is associated with fetal positions such as occiput posterior or transverse, which may lead to the fetal heart being auscultated on the flanks and sub-umbilical flattening.</li><li>\u27a4 anthropoid pelvis</li><li>\u27a4 oval-shaped inlet</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbc247d9",
      "audio": ""
    },
    {
      "text": "If the lower most portion of presenting fetal part at ischial spine, it means the station is at?",
      "options": [
        {
          "label": "A",
          "text": "-1",
          "correct": false
        },
        {
          "label": "B",
          "text": "0",
          "correct": true
        },
        {
          "label": "C",
          "text": "+1",
          "correct": false
        },
        {
          "label": "D",
          "text": "-2",
          "correct": false
        }
      ],
      "correct_answer": "B. 0",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 0</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When the lowermost portion of the presenting fetal part is at the level of the ischial spines , the station is considered to be 0 . Negative stations indicate that the presenting part is higher in the pelvis, while positive stations indicate that it is descending toward delivery.</li><li>\u27a4 ischial spines</li><li>\u27a4 0</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b5828605",
      "audio": ""
    },
    {
      "text": "If the fetus enters the pelvis with its sagittal suture in the transverse diameter of the pelvis, internal rotation will happen by how many degrees?",
      "options": [
        {
          "label": "A",
          "text": "45 degrees",
          "correct": false
        },
        {
          "label": "B",
          "text": "90 degrees",
          "correct": true
        },
        {
          "label": "C",
          "text": "135 degrees",
          "correct": false
        },
        {
          "label": "D",
          "text": "180 degrees",
          "correct": false
        }
      ],
      "correct_answer": "B. 90 degrees",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)\u00a090 degrees</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When the fetal head enters the pelvis in a transverse position , it usually rotates 90 degrees during labor to align the occiput with the anteroposterior diameter of the pelvis, facilitating delivery.</li><li>\u27a4 transverse position</li><li>\u27a4 90 degrees</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "54783440",
      "audio": ""
    },
    {
      "text": "Grade 2 moulding means?",
      "options": [
        {
          "label": "A",
          "text": "Meeting of suture lines",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reducible overlap of suture lines",
          "correct": true
        },
        {
          "label": "C",
          "text": "Irreducible overlap of suture lines",
          "correct": false
        },
        {
          "label": "D",
          "text": "Scalp edema with irreducible overlap of suture lines",
          "correct": false
        }
      ],
      "correct_answer": "B. Reducible overlap of suture lines",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Grade 2 moulding involves a reducible overlap of the suture lines , allowing the fetal skull bones to shift and accommodate the birth canal. This is part of the normal adaptation during labor but should be monitored closely to prevent complications.</li><li>\u27a4 Grade 2 moulding</li><li>\u27a4 reducible overlap of the suture lines</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1a5b870d",
      "audio": ""
    },
    {
      "text": "A midwife at a PHC is monitoring pregnancy and maintaining the partograph of the progression of labor of a 22-year-old primigravida. At how much cervical dilation should the WHO modified partograph plotting be started?",
      "options": [
        {
          "label": "A",
          "text": "2 cm",
          "correct": false
        },
        {
          "label": "B",
          "text": "8 cm",
          "correct": false
        },
        {
          "label": "C",
          "text": "4 cm",
          "correct": true
        },
        {
          "label": "D",
          "text": "6 cm",
          "correct": false
        }
      ],
      "correct_answer": "C. 4 cm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The WHO modified partograph should be started when the cervix is dilated to 4 cm or more, marking the beginning of the active phase of labor , to monitor the progression of labor and manage potential complications effectively.</li><li>\u27a4 WHO modified partograph</li><li>\u27a4 4 cm</li><li>\u27a4 active phase of labor</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "06cb1ea6",
      "audio": ""
    },
    {
      "text": "A 30y old G2 presents in active labor at 9 am. She is 6 cm dilated, well effaced with the Vertex at -1 station. A WHO modified partograph is plotted. At what time do you expect her to be fully dilated?",
      "options": [
        {
          "label": "A",
          "text": "11 am",
          "correct": false
        },
        {
          "label": "B",
          "text": "12 noon",
          "correct": false
        },
        {
          "label": "C",
          "text": "1 pm",
          "correct": true
        },
        {
          "label": "D",
          "text": "2 pm",
          "correct": false
        }
      ],
      "correct_answer": "C. 1 pm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a multiparous woman in active labor, the cervix dilates at approximately 1 cm per hour . If she is 6 cm dilated at 9 am, she is expected to be fully dilated by 1 pm .</li><li>\u27a4 multiparous woman</li><li>\u27a4 1 cm per hour</li><li>\u27a4 6 cm</li><li>\u27a4 1 pm</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88fcf476",
      "audio": ""
    },
    {
      "text": "Which of the following is incorrect regarding the WHO Labor care guide?",
      "options": [
        {
          "label": "A",
          "text": "There is no monitoring of the 2nd stage of labor",
          "correct": true
        },
        {
          "label": "B",
          "text": "Plotting is started after 5 cm",
          "correct": false
        },
        {
          "label": "C",
          "text": "Labor companionship, pain relief posture and fluid intake are all important components.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It follows evidence based time limits at each cm of cervical dilatation",
          "correct": false
        }
      ],
      "correct_answer": "A. There is no monitoring of the 2nd stage of labor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The WHO Labor Care Guide monitors both the first and second stages of labor and begins plotting labor progression after 5 cm cervical dilation . It includes important aspects like labor companionship , pain relief , and fluid intake , and follows evidence-based time limits to ensure proper labor management.</li><li>\u27a4 WHO Labor Care Guide</li><li>\u27a4 first</li><li>\u27a4 second stages of labor</li><li>\u27a4 5 cm cervical dilation</li><li>\u27a4 labor companionship</li><li>\u27a4 pain relief</li><li>\u27a4 fluid intake</li><li>\u27a4 evidence-based time limits</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abd36b92",
      "audio": ""
    },
    {
      "text": "Following delivery of a 4kg baby to a mother with gestational diabetes, you note that there is a tear involving the perineum and external anal sphincter with intact mucosa. The grade of the tear is?",
      "options": [
        {
          "label": "A",
          "text": "First degree",
          "correct": false
        },
        {
          "label": "B",
          "text": "Second degree",
          "correct": false
        },
        {
          "label": "C",
          "text": "Third degree",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fourth degree",
          "correct": false
        }
      ],
      "correct_answer": "C. Third degree",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A third-degree perineal tear involves the external anal sphincter (and sometimes the internal sphincter), but the rectal mucosa remains intact. It is important to recognize the degree of the tear to manage it appropriately and prevent complications such as fecal incontinence.</li><li>\u27a4 third-degree perineal tear</li><li>\u27a4 external anal sphincter</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4b52fc10",
      "audio": ""
    },
    {
      "text": "A 24-year-old G2P1 woman at 39 weeks gestation presents with painful uterine contractions. She also complains of minimal vaginal blood mixed with some mucus. Which of the following describes the most likely etiology of her bleeding?",
      "options": [
        {
          "label": "A",
          "text": "Placenta previa",
          "correct": false
        },
        {
          "label": "B",
          "text": "Placenta abruption",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bloody show",
          "correct": true
        },
        {
          "label": "D",
          "text": "Vasa previa",
          "correct": false
        }
      ],
      "correct_answer": "C. Bloody show",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Bloody show</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A bloody show occurs when the cervix effaces and dilates in preparation for labor, releasing the mucus plug mixed with small amounts of blood. This is a normal finding at the onset of labor and is different from the heavy or more concerning bleeding associated with conditions like placenta previa or placental abruption .</li><li>\u27a4 bloody show</li><li>\u27a4 mucus plug</li><li>\u27a4 placenta previa</li><li>\u27a4 placental abruption</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e8e9e2d",
      "audio": ""
    },
    {
      "text": "A 30-year-old primigravida woman presents at 29 weeks gestation with headache and a blood pressure of 160/110 mm Hg. Investigations reveal 2+ proteinuria on dipstick, an elevated SGOT and SGPT and a platelet count of 80,000/mm3? What is the best management?",
      "options": [
        {
          "label": "A",
          "text": "Oral antihypertensive therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Platelet transfusion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Magnesium sulphate therapy and induction of labor",
          "correct": true
        },
        {
          "label": "D",
          "text": "Intravenous immunoglobulin therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Magnesium sulphate therapy and induction of labor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Magnesium sulphate therapy and induction of labor</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of severe preeclampsia or HELLP syndrome (elevated liver enzymes and low platelets), the best management includes magnesium sulfate to prevent seizures and immediate delivery to prevent further complications for both the mother and fetus. Early delivery is the only definitive treatment.</li><li>\u27a4 severe preeclampsia</li><li>\u27a4 HELLP syndrome</li><li>\u27a4 magnesium sulfate</li><li>\u27a4 immediate delivery</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "579fea3c",
      "audio": ""
    },
    {
      "text": "A 35-year-old primigravida is worried about her risk of developing preeclampsia. What intervention would help reduce the risk in her?",
      "options": [
        {
          "label": "A",
          "text": "Low salt diet",
          "correct": false
        },
        {
          "label": "B",
          "text": "Calcium supplementation started prior to 12 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspirin 150 mg/ day prior to 16 weeks",
          "correct": true
        },
        {
          "label": "D",
          "text": "Antioxidants \u2013 ascorbic acid and \u03b1-tocopherol prior to 12 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. Aspirin 150 mg/ day prior to 16 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For women at high risk of developing preeclampsia , starting low-dose aspirin (75\u2013150 mg/day) before 16 weeks gestation is the most evidence-based intervention to reduce the risk of developing preeclampsia.</li><li>\u27a4 preeclampsia</li><li>\u27a4 low-dose aspirin (75\u2013150 mg/day) before 16 weeks gestation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29a4f3d3",
      "audio": ""
    },
    {
      "text": "All the following precautions are taken in labor in a woman with pre-eclampsia except?",
      "options": [
        {
          "label": "A",
          "text": "Cut short the 2nd stage of labor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prophylactic methylergometrine at the delivery of anterior shoulder",
          "correct": true
        },
        {
          "label": "C",
          "text": "Restrict IV fluids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oxytocin 10U IM following delivery",
          "correct": false
        }
      ],
      "correct_answer": "B. Prophylactic methylergometrine at the delivery of anterior shoulder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In labor management of women with pre-eclampsia , the use of methylergometrine should be avoided due to its potential to cause severe hypertension. Safer alternatives like oxytocin should be used to prevent postpartum hemorrhage.</li><li>\u27a4 pre-eclampsia</li><li>\u27a4 methylergometrine</li><li>\u27a4 oxytocin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f90990c",
      "audio": ""
    },
    {
      "text": "A multiparous patient who did not attend any antenatal visit and came to the emergency room with a complaint of bleeding. On examination, uterine tone was increased with BP >144/92 mmHg. Which of the following tests supports the diagnosis of preeclampsia?",
      "options": [
        {
          "label": "A",
          "text": "Creatinine 1.24 mg/dl",
          "correct": true
        },
        {
          "label": "B",
          "text": "Platelet counts 104000/microL",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alkaline phosphatase 142 IU/L",
          "correct": false
        },
        {
          "label": "D",
          "text": "Total protein of 252mg in a 24 hour urine collection",
          "correct": false
        }
      ],
      "correct_answer": "A. Creatinine 1.24 mg/dl",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Creatinine 1.24 mg/dl</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Serum creatinine >1.1 mg/dL is an indicator of renal involvement in preeclampsia and supports the diagnosis in patients with elevated blood pressure after 20 weeks of gestation. Other indicators, such as thrombocytopenia or proteinuria, may indicate severity but are not always present early in the disease course.</li><li>\u27a4 Serum creatinine >1.1 mg/dL</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "763929bc",
      "audio": ""
    },
    {
      "text": "A 36-year-old primigravida presents with seizures to the emergency. On examination, she is 36 weeks pregnant with BP 150/100 mmHg. She is given a loading dose of magnesium sulfate (MgSO\u2084) as per the Pritchard regime but has another seizure. Which of the following should be done next?",
      "options": [
        {
          "label": "A",
          "text": "Midazolam",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thiopental",
          "correct": false
        },
        {
          "label": "C",
          "text": "Additional magnesium sulphate",
          "correct": true
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": false
        }
      ],
      "correct_answer": "C. Additional magnesium sulphate",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-163911.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Additional magnesium sulphate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of eclampsia with recurrent seizures, the next best step is to administer an additional dose of magnesium sulfate before considering other anticonvulsant options. Magnesium sulfate is the first-line therapy for eclampsia, and adequate dosing should be ensured.</li><li>\u27a4 eclampsia</li><li>\u27a4 additional dose of magnesium sulfate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d4c7487e",
      "audio": ""
    },
    {
      "text": "Which of the following are features of magnesium toxicity in pregnancy: Loss of deep tendon reflex Decreased respiratory rate Decreased urine output Hypertension Increased heart rate",
      "options": [
        {
          "label": "A",
          "text": "a, b, c",
          "correct": false
        },
        {
          "label": "B",
          "text": "a, d, e",
          "correct": false
        },
        {
          "label": "C",
          "text": "a, b",
          "correct": true
        },
        {
          "label": "D",
          "text": "a, b, c, d",
          "correct": false
        }
      ],
      "correct_answer": "C. a, b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) a, b</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Magnesium toxicity in pregnancy is primarily characterized by loss of deep tendon reflexes and decreased respiratory rate . It is crucial to monitor patients receiving magnesium sulfate for these signs to prevent severe complications like respiratory arrest.</li><li>\u27a4 Magnesium toxicity</li><li>\u27a4 loss of deep tendon reflexes</li><li>\u27a4 decreased respiratory rate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "70bdd389",
      "audio": ""
    },
    {
      "text": "Which of the following infections can cause fetal hydrops?",
      "options": [
        {
          "label": "A",
          "text": "Malaria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Parvovirus",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rubella",
          "correct": false
        },
        {
          "label": "D",
          "text": "Varicella",
          "correct": false
        }
      ],
      "correct_answer": "B. Parvovirus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Parvovirus B19 infection is a well-known cause of non-immune hydrops fetalis , characterized by severe fetal anemia and heart failure. Other infections, like rubella , varicella , and malaria , can cause significant fetal complications but are not typically associated with fetal hydrops.</li><li>\u27a4 Parvovirus B19 infection</li><li>\u27a4 non-immune hydrops fetalis</li><li>\u27a4 rubella</li><li>\u27a4 varicella</li><li>\u27a4 malaria</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ae4325eb",
      "audio": ""
    },
    {
      "text": "A 26-year-old test positive for VDRL on routine antenatal investigations. She is 8 weeks pregnant. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Termination of pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Benzathene penicillin 2.4 million units IM single dose",
          "correct": false
        },
        {
          "label": "C",
          "text": "Send fluorescent treponemal antibody absorption test (FTA-ABS)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Repeat VDRL after 2 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. Send fluorescent treponemal antibody absorption test (FTA-ABS)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Send fluorescent treponemal antibody absorption test (FTA-ABS)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A positive VDRL test during pregnancy requires confirmation with a treponemal test such as FTA-ABS to definitively diagnose syphilis. If confirmed, benzathine penicillin is the treatment of choice to prevent maternal and fetal complications.</li><li>\u27a4 VDRL</li><li>\u27a4 treponemal test</li><li>\u27a4 FTA-ABS</li><li>\u27a4 benzathine penicillin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b5287f3",
      "audio": ""
    },
    {
      "text": "A 24-year-old G2P1L1 teacher presents at 38 weeks with fever and rash for 2 days. She gives a history of contact with a child in her class who had chickenpox 10 days earlier. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Consider immediate delivery",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral Acyclovir, antipyretics, and hydration",
          "correct": true
        },
        {
          "label": "C",
          "text": "Varicella Zoster Immunoglobulin (VZIG)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Refer for an urgent ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "B. Oral Acyclovir, antipyretics, and hydration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In pregnant women with active varicella infection , oral acyclovir , along with supportive care such as antipyretics and hydration , is the most appropriate management. Immediate delivery is not necessary unless there are severe complications, and VZIG is only used for post-exposure prophylaxis before symptoms develop.</li><li>\u27a4 active varicella infection</li><li>\u27a4 oral acyclovir</li><li>\u27a4 antipyretics</li><li>\u27a4 hydration</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a2c308c",
      "audio": ""
    },
    {
      "text": "A 27-year G2P1L1 presents at 33 weeks with itching mainly on the palms of her hands. The itching worsens at night. She gives a similar history in her 1 st pregnancy. On examination, her BP is 130/84 mmHg. There is mild icterus and abdominal examination reveals a 32 weeks uterus with fetal heart rate of 140 bpm. Her SGOT is 112 IU/L, SGPT is 124 IU/L and serum bilirubin is 2 mg%. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "Immediate induction of labor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Emergency LSCS",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monitor BP and plan delivery at 37 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Weekly LFT and plan delivery at 38 weeks",
          "correct": true
        }
      ],
      "correct_answer": "D. Weekly LFT and plan delivery at 38 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Weekly LFT and plan delivery at 38 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In intrahepatic cholestasis of pregnancy (ICP), patients with mild to moderate symptoms may be managed with weekly liver function tests (LFTs) and close fetal monitoring, with planned delivery around 38 weeks. This approach minimizes risks associated with both ICP and preterm birth.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1a9806e4",
      "audio": ""
    },
    {
      "text": "A 21-year-old primigravida at 32 weeks presents with jaundice for 3 days. On examination, BP is 140/90 mmHg. Serum bilirubin is 4 mg%, fibrinogen is 50 mg/dl, hemoglobin is 8 g%, platelet count is 90,000/mm\u00b3, RBS is 40 mg/dl, AST is 85, and ALT is 80. Peripheral smear shows normocytic normochromic anemia. What is the most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute Hepatitis A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute Fatty Liver of Pregnancy (AFLP)",
          "correct": true
        },
        {
          "label": "C",
          "text": "HELLP Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cholestasis of pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "B. Acute Fatty Liver of Pregnancy (AFLP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute Fatty Liver of Pregnancy (AFLP) is a serious condition characterized by jaundice , hypoglycemia , coagulopathy , thrombocytopenia , and liver dysfunction in the third trimester. Early recognition and prompt management are crucial to prevent maternal and fetal complications.</li><li>\u27a4 Acute Fatty Liver of Pregnancy (AFLP)</li><li>\u27a4 jaundice</li><li>\u27a4 hypoglycemia</li><li>\u27a4 coagulopathy</li><li>\u27a4 thrombocytopenia</li><li>\u27a4 liver dysfunction</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93a0bf04",
      "audio": ""
    },
    {
      "text": "Under the Anemia Mukt Bharat strategy to reduce the prevalence of anemia, the color of the iron and folic acid tablets given to the adolescent age group are:",
      "options": [
        {
          "label": "A",
          "text": "Red",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pink",
          "correct": false
        },
        {
          "label": "C",
          "text": "Blue",
          "correct": true
        },
        {
          "label": "D",
          "text": "Yellow",
          "correct": false
        }
      ],
      "correct_answer": "C. Blue",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Blue</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the Anemia Mukt Bharat strategy, blue tablets containing 60 mg of elemental iron and 500 mcg of folic acid are provided to adolescents (10-19 years) to address the issue of anemia in this vulnerable group.</li><li>\u27a4 Anemia Mukt Bharat</li><li>\u27a4 blue tablets</li><li>\u27a4 60 mg of elemental iron</li><li>\u27a4 500 mcg of folic acid</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd68931d",
      "audio": ""
    },
    {
      "text": "A 20-year-old G1 is on treatment for iron deficiency anemia with oral iron, which was started at 24 weeks. She visits the antenatal OPD after 1 week. What is the earliest lab evidence of response to therapy?",
      "options": [
        {
          "label": "A",
          "text": "Sense of well being",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rise in Hb level",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reticulocytosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Increase in TIBC",
          "correct": false
        }
      ],
      "correct_answer": "C. Reticulocytosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)\u00a0Reticulocytosis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The earliest laboratory indicator of response to oral iron therapy in the treatment of iron deficiency anemia is reticulocytosis , which occurs within 5-7 days of initiating therapy.</li><li>\u27a4 earliest laboratory indicator</li><li>\u27a4 reticulocytosis</li><li>\u27a4 5-7 days</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1848de82",
      "audio": ""
    },
    {
      "text": "A couple went for pre-conceptional counseling and was detected to be anemic. On investigation, they were both found to have beta thalassemia minor. The chance their fetus will have thalassemia major is:",
      "options": [
        {
          "label": "A",
          "text": "100%",
          "correct": false
        },
        {
          "label": "B",
          "text": "75%",
          "correct": false
        },
        {
          "label": "C",
          "text": "50%",
          "correct": false
        },
        {
          "label": "D",
          "text": "25%",
          "correct": true
        }
      ],
      "correct_answer": "D. 25%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 25%</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When both parents have beta-thalassemia minor , the chance of their child inheriting thalassemia major is 25% , as the condition follows an autosomal recessive inheritance pattern.</li><li>\u27a4 beta-thalassemia minor</li><li>\u27a4 thalassemia major</li><li>\u27a4 25%</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f79aab7f",
      "audio": ""
    },
    {
      "text": "A 25-year-old primigravida with a known history of epilepsy on sodium valproate presents to the antenatal OPD at 6 weeks. Which of the following is incorrect regarding the management of epilepsy in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Folic acid 5 mg to be started pre-conceptionally and continued throughout pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Single anti-epileptic drug at the least dose is preferred during pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sodium valproate is safe",
          "correct": true
        },
        {
          "label": "D",
          "text": "There is an increased risk of developing childhood epilepsy in the fetus",
          "correct": false
        }
      ],
      "correct_answer": "C. Sodium valproate is safe",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Sodium valproate is safe</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sodium valproate should be avoided in pregnancy due to its association with major congenital malformations and neurodevelopmental disorders . Alternative anti-epileptic drugs, such as lamotrigine or levetiracetam , are preferred. Women with epilepsy should receive 5 mg of folic acid pre-conceptionally and throughout pregnancy to reduce the risk of neural tube defects.</li><li>\u27a4 Sodium valproate</li><li>\u27a4 major congenital malformations</li><li>\u27a4 neurodevelopmental disorders</li><li>\u27a4 lamotrigine</li><li>\u27a4 levetiracetam</li><li>\u27a4 5 mg of folic acid</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8a46994",
      "audio": ""
    },
    {
      "text": "A 36-year-old primigravida underwent a targeted imaging for fetal anomalies. On 3-D ultrasound, the following anomaly was noted. What teratogenic drug could have caused this anomaly?",
      "options": [
        {
          "label": "A",
          "text": "Enalapril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metformin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sodium Valproate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Warfarin",
          "correct": false
        }
      ],
      "correct_answer": "C. Sodium Valproate",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-165611.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sodium valproate is a known teratogen associated with cleft lip/palate , neural tube defects , and other congenital anomalies. It should be avoided in pregnancy if possible, and alternative anti-epileptic drugs with lower teratogenic risk should be used.</li><li>\u27a4 Sodium valproate</li><li>\u27a4 cleft lip/palate</li><li>\u27a4 neural tube defects</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f5468fd0",
      "audio": ""
    },
    {
      "text": "When the fetal head is at the perineum and the skull has reached the pelvic floor, which of the following is true?",
      "options": [
        {
          "label": "A",
          "text": "Outlet Forceps can be applied",
          "correct": true
        },
        {
          "label": "B",
          "text": "Best time to give episiotomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Called as crowning",
          "correct": false
        },
        {
          "label": "D",
          "text": "May lead to deep transverse arrest",
          "correct": false
        }
      ],
      "correct_answer": "A. Outlet Forceps can be applied",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Outlet Forceps can be applied</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Outlet forceps can be applied when the fetal head is at the perineum, and this is a safe and common technique in certain situations where assistance in completing the delivery is needed.</li><li>\u27a4 Outlet forceps</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1895580c",
      "audio": ""
    },
    {
      "text": "In the POP-Q system of uterine prolapse, how many fixed points are there?",
      "options": [
        {
          "label": "A",
          "text": "4",
          "correct": false
        },
        {
          "label": "B",
          "text": "6",
          "correct": true
        },
        {
          "label": "C",
          "text": "8",
          "correct": false
        },
        {
          "label": "D",
          "text": "9",
          "correct": false
        }
      ],
      "correct_answer": "B. 6",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 6</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The POP-Q system uses 6 fixed points to assess and quantify pelvic organ prolapse. It provides a standardized, objective approach to describing the severity and extent of prolapse.</li><li>\u27a4 POP-Q system</li><li>\u27a4 6 fixed points</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1e2be509",
      "audio": ""
    },
    {
      "text": "An 89-year-old lady with multiple medical co-morbidities presents with pelvic organ prolapse. She has a grade IV prolapse. Which of the following surgical options would be most appropriate for her?",
      "options": [
        {
          "label": "A",
          "text": "Vaginal hysterectomy with pelvic floor repair",
          "correct": false
        },
        {
          "label": "B",
          "text": "Abdominal sacrocolpopexy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Manchester\u2019s operation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Colpocleisis",
          "correct": true
        }
      ],
      "correct_answer": "D. Colpocleisis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Colpocleisis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For an elderly woman with multiple medical co-morbidities and grade IV pelvic organ prolapse , colpocleisis is the preferred surgical option due to its minimally invasive nature and the lower risk associated with it. This procedure is ideal for patients who are no longer sexually active and wish to avoid more extensive surgery.</li><li>\u27a4 multiple medical co-morbidities</li><li>\u27a4 grade IV pelvic organ prolapse</li><li>\u27a4 colpocleisis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a6cd603e",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman complains of constipation and difficulty having bowel movements. She states that she often needs to use her fingers to push her vagina backward to achieve a bowel movement. Her history is otherwise unremarkable. On examination, the lower part of the posterior vaginal wall is seen to prolapse out. The cervix or the bladder does not descend down on bearing. Which of the following is the best treatment for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Hysterectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anterior colporrhaphy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Posterior colporrhaphy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Resection and repair of enterocele",
          "correct": false
        }
      ],
      "correct_answer": "C. Posterior colporrhaphy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Posterior colporrhaphy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For a patient with rectocele (posterior vaginal wall prolapse), the appropriate treatment is posterior colporrhaphy . This procedure helps repair the rectocele and restores normal vaginal and rectal anatomy, thereby improving symptoms like difficulty with bowel movements.</li><li>\u27a4 rectocele</li><li>\u27a4 posterior colporrhaphy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93ddf2b0",
      "audio": ""
    },
    {
      "text": "A lady underwent vaginal hysterectomy for Carcinoma cervix. Following the surgery after her urethral catheter was removed, she complained of leaking of urine. Methylene blue dye was instilled in her bladder through her urethra, and she was given oral Phenazopyridine dye. After some time, her pads were checked and it showed yellow staining at the top most pad, while the middle or bottom pads were unstained. She is likely to have?",
      "options": [
        {
          "label": "A",
          "text": "Vesicovaginal fistula",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ureterovaginal fistula",
          "correct": true
        },
        {
          "label": "C",
          "text": "Urethrovaginal fistula",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vesicouterine fistula",
          "correct": false
        }
      ],
      "correct_answer": "B. Ureterovaginal fistula",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of yellow-stained pads after administration of phenazopyridine and the absence of blue staining from the methylene blue test indicates a ureterovaginal fistula , where urine is leaking from the ureter directly into the vagina, bypassing the bladder.</li><li>\u27a4 yellow-stained pads</li><li>\u27a4 phenazopyridine</li><li>\u27a4 ureterovaginal fistula</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49c66ad1",
      "audio": ""
    },
    {
      "text": "A -55- years old multigravida with history of frequently micturating due to coughing laughing & sneezing. The diagnosis is?",
      "options": [
        {
          "label": "A",
          "text": "Urge incontinence",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stress incontinence",
          "correct": true
        },
        {
          "label": "C",
          "text": "Neurogenic bladder",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urinary Tract Infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Stress incontinence",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Stress incontinence</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Stress incontinence is the involuntary leakage of urine during activities that increase intra-abdominal pressure, such as coughing , laughing , and sneezing . It is commonly seen in women, especially those with a history of multiple pregnancies or weakened pelvic floor muscles.</li><li>\u27a4 Stress incontinence</li><li>\u27a4 coughing</li><li>\u27a4 laughing</li><li>\u27a4 sneezing</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0731d784",
      "audio": ""
    },
    {
      "text": "At what stage of the female life is the highest number of oocytes found in the ovary?",
      "options": [
        {
          "label": "A",
          "text": "Age 35",
          "correct": false
        },
        {
          "label": "B",
          "text": "At birth",
          "correct": false
        },
        {
          "label": "C",
          "text": "At puberty",
          "correct": false
        },
        {
          "label": "D",
          "text": "In utero at 5 month's gestation",
          "correct": true
        }
      ],
      "correct_answer": "D. In utero at 5 month's gestation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The highest number of oocytes in the female ovary is found in utero at around 5 months of gestation , where approximately 6-7 million oocytes are present. This number declines progressively through life due to atresia.</li><li>\u27a4 in utero at around 5 months of gestation</li><li>\u27a4 6-7 million</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "53b2e181",
      "audio": ""
    },
    {
      "text": "The correct order of lochia during the puerperium is:",
      "options": [
        {
          "label": "A",
          "text": "Rubra, serosa, alba",
          "correct": true
        },
        {
          "label": "B",
          "text": "Serosa, rubra, alba",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alba, serosa, rubra",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alba, mucosa, serosa",
          "correct": false
        }
      ],
      "correct_answer": "A. Rubra, serosa, alba",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Rubra, serosa, alba</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The correct order of lochia during the puerperium is rubra (first stage with red blood), serosa (second stage with pinkish-brown discharge), and finally alba (third stage with whitish or yellowish discharge).</li><li>\u27a4 lochia</li><li>\u27a4 rubra</li><li>\u27a4 serosa</li><li>\u27a4 alba</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1f87158e",
      "audio": ""
    },
    {
      "text": "A patient who delivered few hours back collapses and dies. During autopsy, alveolar fluid analysis shows presence of hair and squamous epithelial cells. Most likely cause of death?",
      "options": [
        {
          "label": "A",
          "text": "Amniotic fluid embolism",
          "correct": true
        },
        {
          "label": "B",
          "text": "Fat embolism",
          "correct": false
        },
        {
          "label": "C",
          "text": "DIC",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary embolism",
          "correct": false
        }
      ],
      "correct_answer": "A. Amniotic fluid embolism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Amniotic fluid embolism</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Amniotic fluid embolism (AFE) is a rare but serious obstetric complication where amniotic fluid or fetal debris enters the maternal circulation, leading to cardiovascular collapse, respiratory failure, and often disseminated intravascular coagulation. The presence of fetal cells (hair and squamous epithelial cells) in the alveolar fluid is diagnostic of AFE.</li><li>\u27a4 Amniotic fluid embolism (AFE)</li><li>\u27a4 fetal cells (hair and squamous epithelial cells)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2c02b83c",
      "audio": ""
    },
    {
      "text": "A 23-year-old woman has just delivered her second baby. She asks the resident for a contraceptive method. The resident suggests an intra-uterine copper-containing device. How soon after delivery can this be inserted?",
      "options": [
        {
          "label": "A",
          "text": "Within 10 mins of placental delivery",
          "correct": true
        },
        {
          "label": "B",
          "text": "Within 24h of delivery",
          "correct": false
        },
        {
          "label": "C",
          "text": "Within 48h of delivery",
          "correct": false
        },
        {
          "label": "D",
          "text": "Within the 1st month of delivery",
          "correct": false
        }
      ],
      "correct_answer": "A. Within 10 mins of placental delivery",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Within 10 mins of placental delivery</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A copper-containing IUD can be safely inserted within 10 minutes of placental delivery, providing effective long-term contraception immediately after childbirth. If not inserted within 48 hours, it is advisable to wait until 4-6 weeks postpartum to minimize the risk of expulsion.</li><li>\u27a4 copper-containing IUD</li><li>\u27a4 within 10 minutes</li><li>\u27a4 4-6 weeks postpartum</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4aa6405b",
      "audio": ""
    },
    {
      "text": "The 4th trimester of pregnancy refers to:",
      "options": [
        {
          "label": "A",
          "text": "The 1st 4 weeks following delivery",
          "correct": false
        },
        {
          "label": "B",
          "text": "The 1st 6 weeks following delivery",
          "correct": false
        },
        {
          "label": "C",
          "text": "The 1st 12 weeks following delivery",
          "correct": true
        },
        {
          "label": "D",
          "text": "The 1st 24 weeks following delivery",
          "correct": false
        }
      ],
      "correct_answer": "C. The 1st 12 weeks following delivery",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The 4th trimester refers to the first 12 weeks following delivery, a critical period for maternal recovery, infant care, and support for physical and mental health.</li><li>\u27a4 4th trimester</li><li>\u27a4 first 12 weeks</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9d402b85",
      "audio": ""
    },
    {
      "text": "A 36-year-old lady with a multiple pregnancy conceived through IVF presents at 32 weeks with painless vaginal bleeding. This is the 2nd such episode, and ultrasound reveals placenta previa. Her pulse rate is 80/min, BP is 110/70 mmHg, FHR 1 is 140 bpm, and FHR 2 is 156 bpm. How will you manage this patient?",
      "options": [
        {
          "label": "A",
          "text": "Immediate cesarean delivery",
          "correct": false
        },
        {
          "label": "B",
          "text": "Expectant management",
          "correct": true
        },
        {
          "label": "C",
          "text": "Arrange blood and plan cesarean at 34 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Induction of labor",
          "correct": false
        }
      ],
      "correct_answer": "B. Expectant management",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Expectant management</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of placenta previa with stable maternal and fetal conditions at 32 weeks, expectant management is the best approach to allow for further fetal maturation. Close monitoring, corticosteroid administration, and planning for delivery at 34-36 weeks (or earlier if complications arise) is the appropriate course of action.</li><li>\u27a4 placenta previa</li><li>\u27a4 expectant management</li><li>\u27a4 34-36 weeks</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ce42abe",
      "audio": ""
    },
    {
      "text": "All are true regarding morbidly adherent placenta except:",
      "options": [
        {
          "label": "A",
          "text": "There is absence of the decidua basalis and Nitabuch layer",
          "correct": false
        },
        {
          "label": "B",
          "text": "MRI is useful in diagnosing accreta in posterior placentas",
          "correct": false
        },
        {
          "label": "C",
          "text": "During cesarean a gentle attempt is made at delivering the placenta and abandoned if there is no separation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Upper segment cesarean is usually performed to deliver the baby",
          "correct": false
        }
      ],
      "correct_answer": "C. During cesarean a gentle attempt is made at delivering the placenta and abandoned if there is no separation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) During cesarean a gentle attempt is made at delivering the placenta and abandoned if there is no separation</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For patients with morbidly adherent placenta , it is crucial not to attempt manual removal of the placenta during cesarean delivery. Instead, the placenta is often left in situ, and further interventions like hysterectomy are planned to prevent life-threatening hemorrhage.</li><li>\u27a4 morbidly adherent placenta</li><li>\u27a4 not to attempt manual removal</li><li>\u27a4 hysterectomy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "835cd271",
      "audio": ""
    },
    {
      "text": "The following type of abnormal placenta is most often associated with placenta previa:",
      "options": [
        {
          "label": "A",
          "text": "Succenturiate placenta",
          "correct": true
        },
        {
          "label": "B",
          "text": "Battledore placenta",
          "correct": false
        },
        {
          "label": "C",
          "text": "Circumvallate placenta",
          "correct": false
        },
        {
          "label": "D",
          "text": "Velamentous cord insertion",
          "correct": false
        }
      ],
      "correct_answer": "A. Succenturiate placenta",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Succenturiate placenta</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Succenturiate placenta is a placental abnormality where one or more accessory lobes develop, and it is most often associated with placenta previa , increasing the risk of the placenta covering the cervical os.</li><li>\u27a4 Succenturiate placenta</li><li>\u27a4 placenta previa</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a710ffd9",
      "audio": ""
    },
    {
      "text": "A 25-year-old primigravida with preeclampsia and fetal distress underwent an emergency LSCS (lower segment cesarean section). Following delivery of the baby, the uterus appeared as shown in the image. What could have been the reason for fetal distress?",
      "options": [
        {
          "label": "A",
          "text": "Abruptio Placenta",
          "correct": true
        },
        {
          "label": "B",
          "text": "CPD",
          "correct": false
        },
        {
          "label": "C",
          "text": "Meconium-stained amniotic fluid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Utero placental insufficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Abruptio Placenta",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-181005.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Abruptio Placenta</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Placental abruption can lead to a Couvelaire uterus , characterized by blood infiltration into the uterine muscle. It is a cause of fetal distress due to compromised placental function, and it requires immediate intervention, often through cesarean delivery.</li><li>\u27a4 Placental abruption</li><li>\u27a4 Couvelaire uterus</li><li>\u27a4 fetal distress</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5ee036ae",
      "audio": ""
    },
    {
      "text": "A 21-year-old primigravida at 36 weeks with chronic hypertension presents with vaginal bleeding and abdominal pain. On examination, her BP is 140/100, the uterus is tense and contracting, and the fetal heart rate is not auscultated. PV examination reveals the cervix is 5 cm dilated and well effaced. What is the next best step in management?",
      "options": [
        {
          "label": "A",
          "text": "ARM + oxytocin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Emergency LSCS",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tocolysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent Ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "A. ARM + oxytocin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of suspected placental abruption with fetal demise and a dilated cervix , ARM and oxytocin augmentation are the preferred management steps to expedite vaginal delivery and minimize risks to the mother. Cesarean section is not necessary if vaginal delivery is feasible.</li><li>\u27a4 placental abruption</li><li>\u27a4 fetal demise</li><li>\u27a4 dilated cervix</li><li>\u27a4 ARM</li><li>\u27a4 oxytocin augmentation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1daa5bd9",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman with a history of hypertension presents to the antenatal clinic for a routine check-up. She is currently 24 weeks pregnant, and her blood pressure is well controlled on a combination of methyldopa and labetalol. She is concerned about the potential risks of these medications to her unborn baby. Which of the following statements about the use of methyldopa and labetalol in pregnancy is correct?",
      "options": [
        {
          "label": "A",
          "text": "Methyldopa and labetalol are contraindicated in pregnancy due to their teratogenic effects.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Methyldopa and labetalol are safe choices for the management of hypertension during pregnancy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Methyldopa is safe, but labetalol should be avoided during pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methyldopa and labetalol can cause intrauterine growth restriction (IUGR) and should be used with caution.",
          "correct": false
        }
      ],
      "correct_answer": "B. Methyldopa and labetalol are safe choices for the management of hypertension during pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Methyldopa and labetalol are safe choices for the management of hypertension during pregnancy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Methyldopa and labetalol are among the preferred antihypertensive medications used during pregnancy due to their safety profiles and effectiveness in managing maternal blood pressure without posing significant risks to the fetus.</li><li>\u27a4 Methyldopa</li><li>\u27a4 labetalol</li><li>\u27a4 safety profiles</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8951bc14",
      "audio": ""
    },
    {
      "text": "A 23-year-old primigravida presents for induction of labor at 41 weeks. Her cervix is unfavorable with a Bishop score of 4. You proceed with cervical ripening using the agent shown below. This medication belongs to which group of drugs?",
      "options": [
        {
          "label": "A",
          "text": "Oxytocin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta mimetics",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prostaglandins",
          "correct": true
        },
        {
          "label": "D",
          "text": "Non Steroidal Anti Inflammatory drugs",
          "correct": false
        }
      ],
      "correct_answer": "C. Prostaglandins",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-172224.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Prostaglandins</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prostaglandins (such as misoprostol and dinoprostone ) are the drugs of choice for cervical ripening during labor induction, especially when the cervix is unfavorable.</li><li>\u27a4 Prostaglandins</li><li>\u27a4 misoprostol</li><li>\u27a4 dinoprostone</li><li>\u27a4 cervical ripening</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "92fd0e29",
      "audio": ""
    },
    {
      "text": "Which of the following is not a test of ovarian reserve?",
      "options": [
        {
          "label": "A",
          "text": "Anti-Mullerian hormone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clomiphene citrate challenge test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Day 2 FSH",
          "correct": false
        },
        {
          "label": "D",
          "text": "Day 10 Antral Follicle Count",
          "correct": true
        }
      ],
      "correct_answer": "D. Day 10 Antral Follicle Count",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Day 10 Antral Follicle Count</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 To assess ovarian reserve , standard tests include the measurement of Anti-Mullerian Hormone (AMH) , Day 2/3 FSH , and the Antral Follicle Count (AFC) done on Day 2 to Day 5 of the menstrual cycle. A Day 10 AFC is not part of the routine assessment of ovarian reserve.</li><li>\u27a4 ovarian reserve</li><li>\u27a4 Anti-Mullerian Hormone (AMH)</li><li>\u27a4 Day 2/3 FSH</li><li>\u27a4 Antral Follicle Count (AFC)</li><li>\u27a4 Day 2 to Day 5</li><li>\u27a4 Day 10 AFC</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0a15bace",
      "audio": ""
    },
    {
      "text": "Which of the following vaccines is not contraindicated in Pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Measles",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rabies",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rubella",
          "correct": false
        },
        {
          "label": "D",
          "text": "Varicella",
          "correct": false
        }
      ],
      "correct_answer": "B. Rabies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Rabies</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Rabies vaccine is an inactivated vaccine and is safe to administer during pregnancy , especially in cases of potential exposure. Live attenuated vaccines like measles , rubella , and varicella are contraindicated during pregnancy due to the potential risk to the fetus.</li><li>\u27a4 Rabies vaccine</li><li>\u27a4 safe to administer during pregnancy</li><li>\u27a4 Live attenuated vaccines</li><li>\u27a4 measles</li><li>\u27a4 rubella</li><li>\u27a4 varicella</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4403fbe0",
      "audio": ""
    },
    {
      "text": "What is the preferred schedule of immunization in pregnancy regarding tetanus as per the ministry of health and family welfare?",
      "options": [
        {
          "label": "A",
          "text": "Inj Td: 1st dose: early in pregnancy, 2nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inj TT 1st dose early in pregnancy, 2nd dose after 4 weeks and booster if received 2 TT doses in a pregnancy within the last 3 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inj Tdap 1st dose in the 2nd trimester and 2nd dose in the 3rd trimester",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inj TT or Td 1st dose in early pregnancy and 2nd dose after 4 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. Inj Td: 1st dose: early in pregnancy, 2nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The preferred schedule for tetanus immunization in pregnancy as per the Ministry of Health and Family Welfare is the Td vaccine , given in two doses\u2014 1st dose early in pregnancy and 2nd dose after 4 weeks . A booster dose is given if the woman has had 2 Td doses in the previous 3 years.</li><li>\u27a4 Ministry of Health and Family Welfare</li><li>\u27a4 Td vaccine</li><li>\u27a4 1st dose early in pregnancy</li><li>\u27a4 2nd dose after 4 weeks</li><li>\u27a4 booster dose</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f02d6de6",
      "audio": ""
    },
    {
      "text": "A 40-year-old woman presents to OPD with complaint of discharge per vagina associated with intense itching. Wet mount of vaginal secretions is shown below. Which of the following is true:",
      "options": [
        {
          "label": "A",
          "text": "Associated with strawberry cervix",
          "correct": true
        },
        {
          "label": "B",
          "text": "Kit 1 will be useful",
          "correct": false
        },
        {
          "label": "C",
          "text": "Will be associated with curdy white discharge",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fluconazole is the treatment of choice",
          "correct": false
        }
      ],
      "correct_answer": "A. Associated with strawberry cervix",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-182932.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Associated with strawberry cervix</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Trichomonas vaginalis infection is characterized by frothy greenish-yellow vaginal discharge , intense itching , and can be associated with a strawberry cervix on examination. It is treated with metronidazole or tinidazole .</li><li>\u27a4 Trichomonas vaginalis</li><li>\u27a4 frothy greenish-yellow vaginal discharge</li><li>\u27a4 intense itching</li><li>\u27a4 strawberry cervix</li><li>\u27a4 metronidazole</li><li>\u27a4 tinidazole</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4dff5b3",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman presents to the OPD with complaints of itching in the vagina, vaginal discharge, and dyspareunia. What is the best treatment option?",
      "options": [
        {
          "label": "A",
          "text": "Vaginal metronidazole",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vaginal clindamycin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vaginal clotrimazole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vaginal estrogen",
          "correct": true
        }
      ],
      "correct_answer": "D. Vaginal estrogen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Vaginal estrogen</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In postmenopausal women with symptoms of vaginal itching , discharge , and dyspareunia , vulvovaginal atrophy (atrophic vaginitis) is the most likely diagnosis, and vaginal estrogen is the best treatment option to relieve symptoms and restore vaginal health.</li><li>\u27a4 vaginal itching</li><li>\u27a4 discharge</li><li>\u27a4 dyspareunia</li><li>\u27a4 vulvovaginal atrophy</li><li>\u27a4 vaginal estrogen</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f55e83bd",
      "audio": ""
    },
    {
      "text": "A 36-year-old P3L3, ligated woman presents to OPD with lower abdominal pain and discharge from vagina. On examination, there is uterine tenderness. What is the likely diagnosis:",
      "options": [
        {
          "label": "A",
          "text": "Candidiasis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pelvic inflammatory disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ectopic pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endometriosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Pelvic inflammatory disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pelvic inflammatory disease</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pelvic inflammatory disease (PID) is characterized by lower abdominal pain , vaginal discharge , and uterine tenderness . It is an infection of the upper reproductive tract, often caused by sexually transmitted pathogens, and requires prompt treatment to avoid complications.</li><li>\u27a4 Pelvic inflammatory disease (PID)</li><li>\u27a4 lower abdominal pain</li><li>\u27a4 vaginal discharge</li><li>\u27a4 uterine tenderness</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ab33c315",
      "audio": ""
    },
    {
      "text": "A 19-year-old girl with a long-standing history of irregular menstrual cycles and amenorrhea presents with an ultrasound picture shown below. Which of the following is least likely to be seen in her?",
      "options": [
        {
          "label": "A",
          "text": "Male pattern hair growth on lower abdomen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thickened dark skin on inner thighs",
          "correct": false
        },
        {
          "label": "C",
          "text": "Abnormal glucose tolerance test results",
          "correct": false
        },
        {
          "label": "D",
          "text": "High serum levels of high-density lipoproteins",
          "correct": true
        }
      ],
      "correct_answer": "D. High serum levels of high-density lipoproteins",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/15/screenshot-2024-07-15-183303.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) High serum levels of high-density lipoproteins</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Polycystic ovary syndrome (PCOS) is characterized by irregular menstrual cycles, hyperandrogenism, and insulin resistance. It is typically associated with low HDL levels, which makes high HDL the least likely feature in patients with PCOS.</li><li>\u27a4 Polycystic ovary syndrome (PCOS)</li><li>\u27a4 low HDL</li><li>\u27a4 high HDL</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45e4637e",
      "audio": ""
    },
    {
      "text": "A 34y G2P1 presents at 35 weeks. She has no complaints and is appreciating fetal movements well. She had a previous classical cesarean at 25 weeks for eclampsia and severe FGR. She is currently on low dose aspirin and prenatal vitamins. On examination, the uterus SFH is 38 cm and FHR is 140 bpm. An ultrasound reveals a single live fetus in breech presentation, placenta posterior and amniotic fluid normal. The patient desires a vaginal delivery. What is the best management?",
      "options": [
        {
          "label": "A",
          "text": "Review USG after 2 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "Schedule elective LSCS at 37 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "ECV at 36 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Await spontaneous labor and then do an internal podalic version",
          "correct": false
        }
      ],
      "correct_answer": "B. Schedule elective LSCS at 37 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Schedule elective LSCS at 37 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For patients with a previous classical cesarean section and breech presentation, an elective cesarean at 37 weeks is recommended to avoid the risk of uterine rupture.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf880bfe",
      "audio": ""
    },
    {
      "text": "A 32-year-old G2 woman with a previous lower segment cesarean section (LSCS) is in labor at 38 weeks. She suddenly experiences vaginal bleeding and loss of uterine contractions. The fetal heart rate (FHR) cannot be auscultated. What is the next best management option?",
      "options": [
        {
          "label": "A",
          "text": "Blood transfusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Emergency laparotomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Urgent ultrasound",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vacuum delivery",
          "correct": false
        }
      ],
      "correct_answer": "B. Emergency laparotomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Emergency laparotomy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a pregnant woman with a previous LSCS who presents with sudden vaginal bleeding , loss of uterine contractions , and inability to auscultate the fetal heart rate, uterine rupture is the most likely diagnosis. Immediate emergency laparotomy is the appropriate management to save the mother's life and attempt to save the fetus if still viable.</li><li>\u27a4 LSCS</li><li>\u27a4 vaginal bleeding</li><li>\u27a4 loss of uterine contractions</li><li>\u27a4 uterine rupture</li><li>\u27a4 emergency laparotomy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8c19cfdd",
      "audio": ""
    },
    {
      "text": "A woman presents to the antenatal OPD and is unsure of her dates. On abdominal examination, external ballottement is elicited. When is the earliest this sign can be seen?",
      "options": [
        {
          "label": "A",
          "text": "6 \u2013 8 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 \u2013 12 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "14 \u2013 16 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "18 \u2013 20 weeks",
          "correct": true
        }
      ],
      "correct_answer": "D. 18 \u2013 20 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 18 \u2013 20 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 External ballottement is a sign that can be detected starting from 18 to 20 weeks of gestation, as the fetus becomes large enough to be palpated and moved within the amniotic fluid.</li><li>\u27a4 External ballottement</li><li>\u27a4 18 to 20 weeks</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d79fc5e",
      "audio": ""
    },
    {
      "text": "The most accurate determination of gestational age in a pregnancy is by:",
      "options": [
        {
          "label": "A",
          "text": "Accurate LMP",
          "correct": false
        },
        {
          "label": "B",
          "text": "CRL on ultrasound",
          "correct": true
        },
        {
          "label": "C",
          "text": "Date of coitus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Date of quickening",
          "correct": false
        }
      ],
      "correct_answer": "B. CRL on ultrasound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) CRL on ultrasound</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Crown-Rump Length (CRL) on ultrasound, measured during the first trimester, is the most accurate method for determining gestational age , as fetal growth is consistent and predictable during this time.</li><li>\u27a4 Crown-Rump Length (CRL)</li><li>\u27a4 gestational age</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "33d39d3d",
      "audio": ""
    },
    {
      "text": "Twin to twin transfusion syndrome has various degrees of severity. This is classified by which staging?",
      "options": [
        {
          "label": "A",
          "text": "Sapporo criteria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Jones staging",
          "correct": false
        },
        {
          "label": "C",
          "text": "Quintero staging",
          "correct": true
        },
        {
          "label": "D",
          "text": "Spiegelberg criteria",
          "correct": false
        }
      ],
      "correct_answer": "C. Quintero staging",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Quintero staging</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Quintero staging system is used to classify the severity of Twin-to-Twin Transfusion Syndrome (TTTS) , which affects monochorionic twin pregnancies. This staging system helps guide management based on the severity of the condition.</li><li>\u27a4 Quintero staging</li><li>\u27a4 Twin-to-Twin Transfusion Syndrome (TTTS)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5ad3a76",
      "audio": ""
    },
    {
      "text": "A 36-year-old lady was diagnosed to have monoamniotic monochorionic twins. She is now 33 weeks. What should be the plan of management?",
      "options": [
        {
          "label": "A",
          "text": "Elective LSCS at 34 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "Elective LSCS at 37 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "Induction of labor at 37 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Wait for spontaneous onset of labor",
          "correct": false
        }
      ],
      "correct_answer": "A. Elective LSCS at 34 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Elective LSCS at 34 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In monoamniotic monochorionic twin pregnancies , elective cesarean section at 34 weeks is the recommended plan of management to reduce the risk of serious complications such as cord entanglement and fetal demise . Vaginal delivery and waiting for spontaneous labor are not recommended in these high-risk pregnancies.</li><li>\u27a4 monoamniotic monochorionic twin pregnancies</li><li>\u27a4 cesarean section at 34 weeks</li><li>\u27a4 cord entanglement</li><li>\u27a4 fetal demise</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "60dde55c",
      "audio": ""
    }
  ]
}